In September, 2018, the U.S. Drug Enforcement Administration announced that certain drug products that have been approved by the Food and Drug Administration (FDA) and which contain cannabidiol (CBD) will be considered Schedule V drugs. Specifically, this order places FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols in schedule V.
Hemp, a non-intoxicating form of the plant Cannabis sativa (L.), was outlawed in the U.S. in 1937 when Congress passed the Marihuana Tax Act. Although most states have legalized hemp in some form since, the federal prohibition meant interstate commerce involving the plant and its derivative products remained illegal. Jenelle Kim, co-founder and lead formulator of hemp product manufacturer JBK Wellness Labs, said the prohibition overshadowed thousands of years of hemp usage in human culture. [Interested in starting a business in the cannabis or hemp industry? Check out our guide to the emerging opportunities in that field.]
Cannabidiol and cannabidiolic acid work by binding to various receptor targets throughout the central nervous system and the rest of the body. Acting at these receptor sites, it exerts influence on the metabolism of various neurotransmitter systems. It seems like ‘snake oil’ that one compound can have all the beneficial effects listed above; however, cannabinoid receptors exist throughout the nervous system and it is known that such a ubiquitous receptor must be involved in nearly everything the nervous system does, just like serotonin and dopamine receptors. Dopamine affects pleasure, but also pain. Anxiety and also relaxation. Heart contraction and blood pressure. All of these systems are integrated so cannabinoid receptors will indeed have effects on all of these systems and exogenous cannabinoids from plants can definitely have therapeutic effects which are extensive.
As you comb through the web pages, it’s clear the product is meant for a multi-level marketing scheme. Many of these companies do not expect anyone to actually use the product. They just want people who will buy it in hopes of selling it to someone else. One previous potential customer has said he could not buy the product, as the company demanded a referral. This means multi-level marketing might be their main business. This can lead to problems getting the product for regular consumers, though they do have an option to sell directly to the consumer as well on the website.
